Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Household cardiovascular screening of high-risk families: a school-based study.
Pourebrahim R, Fakhrzadeh H, Bandarian F, Tabatabaie O, Noori M, Djalilpour F, Zahedi F, Rahimi I, Heshmat R, Djavadi E, Ghotbi S, Larijani B. Pourebrahim R, et al. Eur J Cardiovasc Prev Rehabil. 2006 Apr;13(2):229-35. doi: 10.1097/01.hjr.0000214605.53372.62. Eur J Cardiovasc Prev Rehabil. 2006. PMID: 16575277
Metabolic syndrome and related insulin levels in obese children.
Ebrahimpour P, Fakhrzadeh H, Pourebrahim R, Hamidi A, Larijani B. Ebrahimpour P, et al. Among authors: pourebrahim r. Metab Syndr Relat Disord. 2006 Fall;4(3):172-8. doi: 10.1089/met.2006.4.172. Metab Syndr Relat Disord. 2006. PMID: 18370735
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis.
Senapati J, Muftuoglu M, Ishizawa J, Abbas HA, Loghavi S, Borthakur G, Yilmaz M, Issa GC, Dara SI, Basyal M, Li L, Naqvi K, Pourebrahim R, Jabbour EJ, Kornblau SM, Short NJ, Pemmaraju N, Garcia-Manero G, Ravandi F, Khoury J, Daver N, Kantarjian HM, Andreeff M, DiNardo CD. Senapati J, et al. Among authors: pourebrahim r. Blood Cancer J. 2023 Jun 29;13(1):101. doi: 10.1038/s41408-023-00871-1. Blood Cancer J. 2023. PMID: 37386016 Free PMC article. Clinical Trial.
Targeting Unc51-like Autophagy Activating Kinase 1 (ULK1) Overcomes Adaptive Drug Resistance in Acute Myelogenous Leukemia.
Bhattacharya S, Piya S, Ma H, Sharma P, Zhang Q, Baran N, Ruvolo VR, McQueen T, Davis RE, Pourebrahim R, Konopleva M, Kantarjian H, Cosford NDP, Andreeff M, Borthakur G. Bhattacharya S, et al. Among authors: pourebrahim r. Mol Cancer Res. 2023 Jun 1;21(6):548-563. doi: 10.1158/1541-7786.MCR-22-0343. Mol Cancer Res. 2023. PMID: 36787422 Free PMC article.
20 results